ArticleDrugs & aging2021

Comment on "Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk".

Carlos Antonio Moura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.